Dose Ranging Study of Tissue Plasminogen Activator in Acute Myocardial Infarction: Authors' Reply

BMJ
doi 10.1136/bmj.297.6648.623-b
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Dose Ranging Study of Tissue Plasminogen Activator in Acute Myocardial Infarction.

BMJ
1988English

Ventricular Arrhythmias During Treatment With Alteplase (Recombinant Tissue Plasminogen Activator) in Suspected Acute Myocardial Infarction.

Heart
Cardiovascular MedicineCardiology
1991English

Myocardial Infarction: Authors' Reply

BMJ
1988English

Low-Dose Tissue Plasminogen Activator for Calciphylaxis

Archives of Dermatology
2004English

TNK Tissue Plasminogen Activator Compared With Front-Loaded Alteplase in Acute Myocardial Infarction : Results of the TIMI 10B Trial

Circulation
Cardiovascular MedicinePhysiologyCardiology
1998English

Myocardial Infarction in Asian Men: Authors' Reply

BMJ
1989English

Distribution Patterns of Gd-Dtpa-Enhanced Magnetic Resonance Imaging After Intravenous Tissue Plasminogen Activator Therapy for Acute Myocardial Infarction.

Japanese Circulation Journal
1994English

Alu-Repeat Polymorphism in the Tissue Plasminogen Activator Gene and Risks of Myocardial Infarction in Tunisian Population

Medicinal Chemistry
2016English

Low-Dose Versus Standard-Dose Tissue Plasminogen Activator for Intravenous Thrombolysis in Asian Acute Ischemic Stroke Patients

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy